Lipid-based dispersions of exemestane for improved dissolution rate and intestinal permeability: in vitro and ex vivo characterization

References

• Bandari S, Jadav S, Eedara BB, Dhurke R, Jukanti R. 2014. Enhancement of solubility and dissolution rate of loratadine with Gelucire 50/13. J Pharm Innov. 9:141–149.
   Web of Science ®Google Scholar
• Bandari S, Jadav S, Eedara BB, Jukanti R, Veerareddy PR. 2013. Physicochemical characterization and dissolution enhancement of loratadine by solid dispersion technique. Korean J Chem Eng. 30:238–244.
   Web of Science ®Google Scholar
• Bikiaris D, Papageorgiou GZ, Stergiou A, Pavlidou E, Karavas E, Kanaze F, Georgarakis M. 2005. Physicochemical studies on solid dispersions of poorly water-soluble drugs: evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta. 439:58–67.
   Web of Science ®Google Scholar
• Carr RL. 1965. Evaluating flow properties of solids. Chem Eng. 72:163–168.
   Google Scholar
• Dintaman JM, Silverman JA. 1999. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res. 16:1550–1556.
   PubMed Web of Science ®Google Scholar
• Eedara BB, Kallakunta VR, Bandari S. 2015. Self-nanoemulsifying powders for improved oral delivery of poorly water-soluble drugs. Ther Deliv. 6:899–901.
   PubMedGoogle Scholar
• Eedara BB, Kankane M, Jukanti R, Nagabandi VK, Bandari S. 2013. Enhanced solubility and permeability of exemestane solid dispersion powders for improved oral delivery. J Pharm Investig. 43:229–242.
   Google Scholar
• Eedara BB, Veerareddy PR, Jukanti R, Bandari S. 2014. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies. Drug Dev Ind Pharm. 40:1030–1043.
   PubMed Web of Science ®Google Scholar
• Fenyvesi F, Kiss T, Fenyvesi É, Szente L, Veszelka S, Deli MA, Bácskay I. 2011. Randomly methylated β-cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco-2 cell monolayer. J Pharm Sci. 100:4734–4744.
   PubMed Web of Science ®Google Scholar
• Fernandez S, Rodier JD, Ritter N, Mahler B, Demarne F, Carriere F, Jannin V. 2008. Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases. Biochim Biophys Acta. 1781:367–375.
   PubMed Web of Science ®Google Scholar
• Frank KJ, Westedt U, Rosenblatt KM, Hölig P, Rosenberg J, Mägerlein M, Brandl M. 2014. What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? J Pharm Sci. 103:1779–1786.
   PubMed Web of Science ®Google Scholar
• Gangishetty H, Eedara BB, Bandari S. 2015. Development of ketoprofen loaded proliposomal powders for improved gastric absorption and gastric tolerance: in vitro and in situ evaluation. Pharm Dev Technol. 20:641–651.
   PubMed Web of Science ®Google Scholar
• Goss P, von Eichel L. 2007. Summary of aromatase inhibitor trials: the past and future. J Steroid Biochem Mol Biol. 106:40–48.
   PubMed Web of Science ®Google Scholar
• Graig DQM. 2002. The mechanism of drug release from solid dispersion in water soluble polymers. Int J Pharm. 231:131–144.
   PubMed Web of Science ®Google Scholar
• Higuchi J, Connors K. 1965. Phase solubility techniques. Adv Anal Chem Instrum. 4:117–212.
   Google Scholar
• Inugala S, Eedara BB, Sunkavalli S, Dhurke R, Kandadi P, Jukanti R, Bandari S. 2015. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: in vitro and in vivo evaluation. Eur J Pharm Sci. 74:1–10.
   PubMed Web of Science ®Google Scholar
• Kallakunta VR, Eedara BB, Jukanti R, Ajmeera RK, Bandari S. 2013. A Gelucire 44/14 and labrasol based solid self-emulsifying drug delivery system: formulation and evaluation. J Pharm Investig. 43:185–196.
   Google Scholar
• Karata A, Yüksel N, Baykara T. 2005. Improved solubility and dissolution rate of piroxicam using Gelucire 44/14 and labrasol. Farmaco. 60:777–782.
   PubMedGoogle Scholar
• Kaufmann M, Bajetta E, Dirix LY, Fein LE, Jones SE, Zilembo N, et al. 2000. Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. J Clin Oncol. 18:1399–1411.
   PubMed Web of Science ®Google Scholar
• Kawakami K, Miyoshi K, Ida Y. 2004. Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent. J Pharm Sci. 93:1471–1479.
   PubMed Web of Science ®Google Scholar
• Khoo SM, Porter CJ, Charman WN. 2000. The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment. Int J Pharm. 205:65–78.
   PubMed Web of Science ®Google Scholar
• Kristina SB, Andrea T, Stephen DL, Kishor MW. 2007. Lipid excipients peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within caco-2 cells. J Pharm Pharm Sci. 10:319–331.
   PubMed Web of Science ®Google Scholar
• Löbenberg R, Amidon GL. 2000. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm. 50:3–12.
   PubMed Web of Science ®Google Scholar
• Majerik V, Charbit G, Badens E, Horváth G, Szokonya L, Bosc N, Teillaud E. 2007. Bioavailability enhancement of an active substance by supercritical anti-solvent precipitation. J Supercrit Fluids. 40:101–110.
   Web of Science ®Google Scholar
• Neupane YR, Srivastava M, Ahmad N, Kumar N, Bhatnagar A, Kohli K. 2014. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment. Int J Pharm. 477:601–612.
   PubMed Web of Science ®Google Scholar
• Odon P, Borut K, Franc V. 2011. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica. Int J Pharm. 406:41–48.
   PubMed Web of Science ®Google Scholar
• Ozeki T, Takashima Y, Nakano T, Yuasa H, Kataoka M, Yamashita S, Tatsumi T, Okada H. 2011. Preparation of spray-dried microparticles using Gelucire 44/14 and porous calcium silicate or spherical microcrystalline cellulose to enhance transport of water-insoluble pranlukast hemihydrate across Caco-2 monolayers. Adv Powder Technol. 22:623–628.
   Web of Science ®Google Scholar
• Ramasahayam B, Eedara BB, Kandadi P, Jukanti R, Bandari S. 2015. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 41:753–763.
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. 1999. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 88:1058–1066.
   PubMed Web of Science ®Google Scholar
• Sheu MT, Chen SY, Chen LC, Ho HO. 2003. Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol. J Control Release. 88:355–368.
   PubMed Web of Science ®Google Scholar
• Singh AK, Chaurasiya A, Singh M, Upadhyay SC, Mukherjee R, Khar RK. 2008. Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization. AAPS PharmSciTech. 9:628–634.
   PubMed Web of Science ®Google Scholar
• Sunkavalli S, Eedara BB, Janga KY, Velpula A, Jukanti R, Bandari S. 2016. Preparation and characterization of docetaxel self-nanoemulsifying powders (SNEPs): a strategy for improved oral delivery. Korean J Chem Eng. 33:1115–1124.
   Web of Science ®Google Scholar
• Taylor LS, Zografi G. 1997. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res. 14:1691–1698.
   PubMed Web of Science ®Google Scholar
• van den Mooter G, Weuts I, Ridder DT, Blaton N. 2006. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int J Pharm Sci. 26:219–230.
   Google Scholar
• Vasanthavada M, Serajuddin ATM. 2007. Lipid-based self-emulsifying solid dispersions. In: Hauss DJ, Ed. Oral Lipid-Based Formulations: Enhancing Bioavailability of Poorly Water-Soluble Drugs. New York, London: Informa Healthcare, pp. 149–184.
   Google Scholar
• Yavuz B, Bilensoy E, Sumnu M. 2007. Bioavailability file: exemestane. FABAD J Pharm Sci. 32:79–89.
   Google Scholar
• Yavuz B, Bilensoy E, Vural I, Sumnu M. 2010. Alternative oral exemestane formulation: improved dissolution and permeation. Int J Pharm. 398:137–145.
   PubMed Web of Science ®Google Scholar
• Yu L, Bridgers A, Polli J, Vickers A, Long S, Roy A, Winnike R, Coffin M. 1999. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res. 16:1812–1817.
   PubMed Web of Science ®Google Scholar
• Yuasa H, Asahi D, Takashima Y, Kanaya Y, Shinozawa K. 1994. Application of calcium silicate for medicinal preparation. I. Solid preparation adsorbing an oily medicine to calcium silicate. Chem Pharm Bull. 42:2327–2331
   PubMed Web of Science ®Google Scholar
• Yuksel N, Karata A, Özkan Y, Savaer A, Özkan AS, Baykara T. 2003. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 56:453–459.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen Y, Deng J, Jia X, Zhou J, Lv H. 2014. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO2: preparation, characterization and in vivo studies. Int J Pharm. 465:306–316.
   PubMed Web of Science ®Google Scholar